Aisling Capital as of June 30, 2014
Portfolio Holdings for Aisling Capital
Aisling Capital holds 13 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Versartis | 16.2 | $56M | 2.0M | 28.04 | |
| Transenterix | 12.1 | $42M | 8.3M | 5.04 | |
| Zeltiq Aesthetics | 11.6 | $40M | 2.6M | 15.19 | |
| Cempra | 10.3 | $36M | 3.3M | 10.73 | |
| Durata Therapeutics | 10.0 | $35M | 2.0M | 17.03 | |
| Chimerix (CMRX) | 9.7 | $33M | 1.5M | 21.94 | |
| Esperion Therapeutics (ESPR) | 9.4 | $33M | 2.1M | 15.84 | |
| Agile Therapeutics | 5.5 | $19M | 2.2M | 8.72 | |
| Pernix Therapeutics Holdings | 5.2 | $18M | 2.0M | 8.98 | |
| Sorrento Therapeutics (SRNE) | 3.4 | $12M | 1.8M | 6.75 | |
| Ambit Bioscience | 3.3 | $11M | 1.7M | 6.91 | |
| Lombard Med (EVARF) | 1.8 | $6.4M | 886k | 7.20 | |
| Mei Pharma | 1.4 | $4.9M | 770k | 6.34 |
